Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
See Latest ArticlesNeuromyelitis optica: current concepts and prospects for future management
Current Opinion in Ophthalmology, 10/16/09
Hazin R et al. – Clinical features of NMO include visual loss, decreased coordination, widespread asthenia, paraplegia, quadriplegia, and sensory impairment. Severe cases can result in bladder and bowel impairment or fatal respiratory failure. Symptomatic treatment and the currently available therapeutic agents can control the disease in many patients. However, given the lack of a curative treatment, the prognosis of NMO remains poor in some patients underscoring the need for drug development and controlled clinical trials focused on improved treatment strategies.
Related Articles
Western blot analysis for the detection of serum antibodies recognizing linear Aquaporin-4 epitopes in patients with Neuromyelitis Optica
Journal of Neuroimmunology, 10/26/09
Relevance Score: 66%
"Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica
Annals of Neurology, 10/08/09
Relevance Score: 65%
Patient with neuromyelitis optica and inflammatory demyelinating lesions comprising whole spinal cord from C2 level till conus: case report
BMC Neurology, 10/29/09
Relevance Score: 64%
Review: Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms
Therapeutic Advances in Neurological Disorders, 11/10/09
Relevance Score: 62%
Today in Neuro-Ophthalmology...keeping you current
Receive free subspecialty "5-minute updates" via email
Timing of Corticosteroid Therapy is Critical to Prevent Retinal Ganglion Cell Loss in Experimental Optic Neuritis
Investigative Ophthalmology and Visual Science, 11/20/09
A Comparison of Optic Nerve Head Morphology Viewed by Spectral Domain Optical Coherence Tomography and By Serial Histology
Investigative Ophthalmology and Visual Science, 11/19/09
Clusterin inhibits blood-retinal barrier breakdown in diabetic retinopathy
Investigative Ophthalmology and Visual Science, 11/19/09
Article Search
Sponsor